|
Revenue
|
1.44M | 1.38M |
|
Cost of Revenue
|
0.45M | 0.55M |
|
Gross Profit
|
0.99M | 0.98M |
|
Research & Development
|
0.15M | 0.05M |
|
Selling, General & Administrative
|
1.65M | 3.62M |
|
Restructuring Costs
|
0.22M | 0.69M |
|
Other Operating Expenses
|
-0.09M | -0.14M |
|
Operating Expenses
|
1.93M | 4.23M |
|
Operating Income
|
-0.94M | -3.25M |
|
EBIT
|
-0.94M | -3.25M |
|
Other Non Operating Income
|
0.00M | 0.02M |
|
Non Operating Income
|
| 0.12M |
|
EBT
|
-0.94M | -3.14M |
|
Tax Provisions
|
| 0.01M |
|
Profit After Tax
|
-0.94M | -3.14M |
|
Income from Continuing Operations
|
-0.94M | -3.14M |
|
Consolidated Net Income
|
-0.94M | -3.14M |
|
Income towards Parent Company
|
-0.94M | -3.14M |
|
Net Income towards Common Stockholders
|
-0.94M | -3.14M |
|
EPS (Basic)
|
-0.10 | -0.29 |
|
EPS (Weighted Average and Diluted)
|
-0.10 | -0.29 |
|
Shares Outstanding (Weighted Average)
|
10.03M | 12.10M |
|
Shares Outstanding (Diluted Average)
|
9.50M | 11.01M |
|
EBITDA
|
-0.94M | -3.14M |